• Japanese
  • Korean
  • Chinese
Home > Pharmaceutical > Drug Discovery > Clinical Development Market Research Reports
Category
Pharmaceutical (6877)
Biologics (269)
Biomarker (101)
Cancer (1063)
Clinical Trial (931)
Diabetes (182)
Drug Delivery System (139)
Drug Discovery (445)
Drug Regulation (122)
Gene Therapeutics & RNAi (95)
Generic Drugs (104)
Genome-based Drug Discovery (151)
Infectious Disease (337)
Molecular Targeted Therapeutics (200)
Neurodegenerative Disease (231)
OTC Drug (105)
Personalized Medicine (60)
Pharmaceutical Companies (954)
Pipeline Analysis (1767)
Prescription Drugs (514)
Regenerative Medicine (138)
Vaccines (230)

Clinical Development Market Research Reports

We offer market research, industry forecasts, and business analysis in the Clinical Development as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis.

  • All (445)
  • Clinical Development (11)
  • CRO (28)

Filter
Title Search
1 - 11 of 11 Products Sort by Display
*
Product code:290984
Published by Cutting Edge Information
Published November 30, 2013 Price USD 7695
Content info 221 Pages
Sample available
*
Product code:258253
Published by Cutting Edge Information
Published January 1, 2013 Price USD 7695
Content info 112 Pages
Sample available
*
Product code:250522
Published by Business Insights
Published August 28, 2012 Price USD 2875
Content info 40 Pages
Sample available
Clinical Development and Trial Design - Developing a Coherent Approach From Beginning to End
Product code:290383
Published by CBR Pharma Insights
Published June 15, 2012 Price USD 3900
Content info 48 Pages
Sample available
*
Product code:189452
Published by Cutting Edge Information
Published April 22, 2011 Price USD 7695
Content info 174 Pages
Sample available
The current patent cliff, shrinking pipelines, and the impact of a global recession place heightened pressure on the clinical development landscape....
Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Product code:227393
Published by GBI Research
Published February 10, 2011 Price USD 3500
Content info 209 Pages
Sample available
This report provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders....
Competitor Analysis: Cancer Antibodies in Early Clinical Development
Product code:166719
Published by La Merie Publishing
Published February 1, 2011 Price USD 1135
Content info 183 Pages
Sample available
The report includes a compilation of currently active projects in early clinical research and development of antibody therapeutic for treatment of cancer....
*
Product code:143474
Published by Cutting Edge Information
Published November 30, 2010 Price USD 7695
Content info 275 Pages
Sample available
The next frontier of global industry expansion makes its home in Brazil, Russia, India and China (BRIC). Imagine the impact of a patient pool that numbers 3 billion - an immediate cure for patient shortages (or recruitment challenges) that plague studies ...
*
Product code:143473
Published by Cutting Edge Information
Published November 30, 2010 Price USD 7695
Content info 193 Pages
Sample available
Asia offers clinical development teams unique benefits for running trials. Among emerging markets, Asian countries offer the highest number of available patients....
*
Product code:143472
Published by Cutting Edge Information
Published November 30, 2010 Price USD 7695
Content info 187 Pages
Sample available
The countries in Central and Eastern Europe provide ample opportunity for life sciences companies, especially in terms of clinical development....
*
Product code:143471
Published by Cutting Edge Information
Published November 30, 2010 Price USD 7695
Content info 117 Pages
Sample available
Despite maintaining regional offices within Africa, many major drug and device manufacturers frequently overlook the continent when sponsoring clinical studies. Cultural barriers, political upheaval and uneven infrastructure are certainly causes for the l...